Shanghai, China

Weiqiang Xing

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: Weiqiang Xing: Innovator in Pharmaceutical Chemistry

Introduction: Weiqiang Xing is a notable inventor based in Shanghai, China, recognized for his contributions to pharmaceutical chemistry. With a total of nine patents to his name, Xing has made significant advancements in the field, particularly in the development of new compounds and their medical applications.

Latest Patents: Among his latest innovations, Xing has developed two notable patents. The first is titled "Phthalazinone compound, and preparation method therefor and medical use thereof." This patent discloses a phthalazinone compound and details a preparation method along with its medical applications, particularly its use in degrading the androgen receptor (AR). The second patent focuses on "Heterocyclic GLP-1 agonists," which relates to GLP-1 agonists of Formula (I), including pharmaceutically acceptable salts and solvates, as well as pharmaceutical compositions that include these compounds.

Career Highlights: Xing's career has been marked by his work with prominent companies in the biotech and pharmaceutical industries. Notably, he has been associated with GlaxoSmithKline Intellectual Property Development Limited and Gasherbrum Bio, Inc., where he has applied his expertise in innovation and patent development to drive advancements in healthcare solutions.

Collaborations: Throughout his career, Weiqiang Xing has collaborated with talented coworkers such as Feng Ren and Yingxia Sang. These collaborations have allowed for a productive exchange of ideas and knowledge, further propelling Xing's innovative endeavors in pharmaceutical research.

Conclusion: Weiqiang Xing continues to lead in the realm of pharmaceutical innovation with his groundbreaking patents and collaborations. His work in developing new compounds such as phthalazinone and heterocyclic GLP-1 agonists highlights his commitment to enhancing medical therapies and improving patient outcomes. As an inventor, Xing's contributions underscore the importance of innovation in the ever-evolving landscape of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…